Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium

NARecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 4, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Carbetocin

Carbetocin first bolus 10-8 M (equivalent to 100 mcg) will be added to the muscle bath to create ex-vivo environment similar to Cesarean delivery, and after 20 minutes the baths will be washed three time with physiological salt solution (PSS).

DRUG

Oxytocin

Oxytocin 10-5M will be added to all strips for 2 hours to induce desensitization.

DRUG

Carbetocin

Increasing concentrations of carbetocin in a pattern of 1 log molar increase every 10 min, from 10-5 M to 10-5 M

DRUG

Oxytocin

Increasing concentrations of oxytocin from 10-10 M to 10-5 M

DRUG

Ergonovine

Increasing concentrations of ergometrine from 10-10 M to 10-5 M

DRUG

Carboprost

Increasing concentrations of carboprost from 10-10 M to 10-5 M

Trial Locations (1)

M5G1X5

RECRUITING

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER